Latest Period
Q1 2026
Security Snapshot
Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) Institutional Ownership
CUSIP: 690145206
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
93
Shares (Excl. Options)
14,763,535
Price
$3.84
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value of $0.001 per share
- Symbol
- OM on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 14,763,535
- Total 13F value
- $56,664,230
- Portfolio coverage rank
- 0%
- Share change
- -709,780
- Value change
- -$2,416,808
- Number of holders
- 93
- Shares outstanding
- 18,116,200
- SEC-reported price per share
- $3.89
- Insider filing price
- $3.89
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share is tracked under CUSIP 690145206.
- 93 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 94 to 93 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $56,944,212 to $56,664,230.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 93 institutions filings for Q1 2026.
Security key
690145206
Latest holder period
Q1 2026
13F holders
93
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
OM full holder history
Outset Medical, Inc. SEC filings
Outset Medical, Inc. company facts
Outset Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 690145206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
OM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | $30,149,556 | 2,596,861 | FMR LLC | 31 Mar 2025 | |||
| BML Investment Partners, L.P. | 10% | +12% | $9,739,269 | +$1,005,184 | 1,902,201 | +12% | BML Investment Partners, L.P. | 12 Feb 2026 |
| Woodline Partners LP | 7.5% | $15,392,352 | 1,325,784 | Woodline Partners LP | 31 Mar 2025 | |||
| BlackRock, Inc. | 6.8% | +22% | $17,135,284 | +$3,284,072 | 1,213,547 | +24% | BlackRock, Inc. | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC | 6.7% | $14,028,758 | 1,208,334 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| VANGUARD GROUP INC | 5.6% | $18,919,737 | 991,429 | The Vanguard Group | 30 Jun 2025 | |||
| BANK OF AMERICA CORP /DE/ | 5.2% | $4,866,857 | 950,558 | BANK OF AMERICA CORP /DE/ | 31 Dec 2025 | |||
| T. Rowe Price Investment Management, Inc. | 0% | -99% | $33,874 | -$22,601,277 | 2,399 | -100% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
As of 31 Mar 2026, 93 institutional investors reported holding 14,763,535 shares of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM). This represents 81% of the company’s total 18,116,200 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
76%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 2,741,673 | +3.8% | 0% | $10,528,024 |
| BML Capital Management, LLC | 10% | 1,902,201 | +250% | 4.7% | $7,304,452 |
| BlackRock, Inc. | 7% | 1,263,219 | -2% | 0% | $4,850,761 |
| BANK OF AMERICA CORP /DE/ | 5.2% | 949,397 | -0.12% | 0% | $3,645,685 |
| PERCEPTIVE ADVISORS LLC | 4.6% | 833,333 | 0% | 0.06% | $3,199,998 |
| AQR CAPITAL MANAGEMENT LLC | 4.5% | 808,285 | +348% | 0% | $3,103,815 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 763,822 | 0% | 0% | $2,933,076 |
| PFM Health Sciences, LP | 3.3% | 594,630 | +12% | 0.24% | $2,283,379 |
| Ensign Peak Advisors, Inc | 2.9% | 526,585 | -6% | 0% | $2,022,086 |
| Assenagon Asset Management S.A. | 2.8% | 504,093 | -0.85% | 0% | $1,935,717 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 421,373 | +5.2% | 0% | $1,618,440 |
| STATE STREET CORP | 1.8% | 334,994 | +1.5% | 0% | $1,286,377 |
| Woodline Partners LP | 1.6% | 292,437 | -78% | 0% | $1,122,958 |
| UBS Group AG | 1.4% | 252,499 | +245% | 0% | $969,596 |
| RENAISSANCE TECHNOLOGIES LLC | 1.2% | 222,075 | +391% | 0% | $852,768 |
| Stratos Wealth Partners, LTD. | 1.1% | 200,546 | 0.01% | $770,097 | |
| MORGAN STANLEY | 0.94% | 169,443 | +21% | 0% | $650,660 |
| XTX Topco Ltd | 0.79% | 142,450 | +42% | 0.01% | $547,008 |
| NORTHERN TRUST CORP | 0.69% | 125,437 | -46% | 0% | $481,678 |
| Catalio Capital Management, LP | 0.65% | 118,279 | 0% | 0.09% | $454,191 |
| DIMENSIONAL FUND ADVISORS LP | 0.63% | 113,365 | -28% | 0% | $435,032 |
| VANGUARD FIDUCIARY TRUST CO | 0.62% | 111,639 | 0% | 0% | $428,694 |
| JPMORGAN CHASE & CO | 0.56% | 100,977 | -7.7% | 0% | $364,527 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.54% | 98,610 | 0% | 0% | $378,662 |
| GOLDMAN SACHS GROUP INC | 0.52% | 93,360 | +28% | 0% | $358,503 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 14,763,535 | $56,664,230 | -$2,416,808 | $3.84 | 93 |
| 2025 Q4 | 15,349,620 | $56,944,212 | -$38,452,367 | $3.71 | 94 |
| 2025 Q3 | 17,649,176 | $249,202,204 | -$11,456,191 | $14.12 | 96 |
| 2025 Q2 | 18,242,288 | $350,434,222 | +$69,197,262 | $19.21 | 91 |
| 2025 Q1 | 14,676,599 | $162,319,841 | +$162,319,498 | $11.06 | 59 |